Taysha Gene Therapies
Price & Volume
Stats
See more52W Range | $1.19-$4.32 |
Market Cap | $358.7M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $8.3M |
Revenue Growth (YoY) | -43.9% |
Gross Profit (12 Mos) | $8.3M |
Diluted EPS | -$0.36 |
News
See moreYahoo Finance • 2 days ago
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 5 months ago
Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?
Yahoo Finance • last year
Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients
Yahoo Finance • last year
Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares
About
CEO | Mr. Sean P. Nolan |
CFO | Mr. Kamran Alam CPA, M.B.A. |
Address | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
